The chemical class known as UIP5 activators encompasses a variety of compounds that can influence the activity of the UIP5 protein, an E3 ubiquitin ligase involved in the ubiquitin-proteasome system. These activators do not directly bind to UIP5 in the way that substrates or inhibitors might interact with other proteins; instead, they exert their influence over UIP5 activity through modulation of cellular pathways and stress responses in which UIP5 plays a critical role. The activators often target processes that indirectly necessitate an increase in the ubiquitination activity associated with UIP5, such as proteasome inhibition, which leads to an accumulation of ubiquitinated proteins. This accumulation creates a cellular demand for enhanced ubiquitin ligase activity to restore homeostasis, thereby upregulating UIP5's role in protein degradation.
Another method by which these activators can influence UIP5 involves the induction of cellular stress, particularly within the endoplasmic reticulum (ER), where unfolded or misfolded proteins accumulate. In response to this stress, the unfolded protein response (UPR) is activated, which may include an increase in the degradation of misfolded proteins through the ER-associated degradation (ERAD) pathway. UIP5 can be implicated in this process, as its ubiquitin ligase activity is essential for targeting specific proteins for degradation. Other activators may work by inhibiting molecular chaperones like Hsp90, leading to a surge in misfolded client proteins that require ubiquitination, or by influencing autophagy pathways, thereby indirectly necessitating enhanced activity of UIP5 to compensate for the inhibited degradation pathways. Each activator within this chemical class is capable of altering the delicate balance of protein synthesis and degradation, which in turn can modulate the functional dynamics of UIP5 within the cell.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $135.00 $1085.00 | 115 | |
As a proteasome inhibitor, this compound could possibly activate UIP5 by creating a backlog of proteins to be ubiquitinated, indirectly stimulating its activity. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
Triggers ER stress which could possibly activate UIP5 by enhancing ERAD activity, where UIP5 functions to target misfolded proteins for degradation. | ||||||
Tunicamycin | 11089-65-9 | sc-3506A sc-3506 | 5 mg 10 mg | $172.00 $305.00 | 66 | |
Induces ER stress which could possibly activate UIP5 by increasing the demand for its role in the ERAD pathway in response to misfolded glycoproteins. | ||||||
Celastrol, Celastrus scandens | 34157-83-0 | sc-202534 | 10 mg | $158.00 | 6 | |
Induces heat shock response and could possibly activate UIP5 by elevating the ubiquitination demand for misfolded proteins. | ||||||
Salubrinal | 405060-95-9 | sc-202332 sc-202332A | 1 mg 5 mg | $34.00 $104.00 | 87 | |
Inhibits eIF2α dephosphorylation and could possibly activate UIP5 by enhancing ER stress and subsequently UIP5-mediated ERAD. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Can modulate GSK-3β and Wnt signaling, and could possibly activate UIP5 by influencing ubiquitination processes in these pathways. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $31.00 $47.00 $84.00 $222.00 | 19 | |
Acts as a histone deacetylase inhibitor and could possibly activate UIP5 by altering gene expression patterns and protein stability. | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $37.00 $69.00 $109.00 $218.00 $239.00 $879.00 $1968.00 | 47 | |
Modulates various signaling pathways and stress responses, which could possibly activate UIP5 through its broad biological effects. | ||||||